期刊文献+

泛素羧基端水解酶-L1基因两种多态与帕金森病发病的相关性 被引量:2

Association of two polymorphisms in ubiquitin carboxy-terminal hydrolase-L1 gene with Parkinson's disease in Shanghai
原文传递
导出
摘要 目的探讨泛素羧基端水解酶-L1基因(ubiquitin carboxy-terminal hydrolase-L1,UCH-L1)第3外显子C/A多态、第4外显子C/T多态与帕金森病(Parkinson’s disease,PD)发病风险的关系。方法采用聚合酶链反应.限制性片段长度多态性方法,在164例PD患者和172名健康对照者中观察UCH-L1基因C/A和C/T多态的分布,并通过比值比(oddsratio,D刖进行相关分析。结果(1)PD患者中UCH-L1第3外显子上C等位基因的频率(62.2%)明显高于对照组(51.7%)(OR=1.53,P=0.006),PD患者CC基因型的频率(36.6%)亦明显高于对照组(23.2%)(OR=1.90,P=0.008)。(2)PD患者中UCH-L1第4外显子上C/T等位基因和基因型的频率分布在PD患者和对照组问差异无统计学意义。结论UCH-L1第3外显子上C等位基因可能是PD发病的危险因子,而第4外显子上的C/T多态则与PD发病无关。 Objective To explore the relationship of polymorphisms in the ubiquitin carboxy-terminal hydrolase- L1 (UCH-L1)gene with Parkinson' s disease(PD)in Shanghai Han Nationality. Methods The distribution of a Serine18Tyrosine polymorphism in exon 3 (C/A) and a Serine89Phenylalanine polymorphism in exon 4(C/T) of UCH-L1 gene were detected in 164 PD cases and 172 healthy controls, using polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP) method. Results (1)The C allelic frequency in exon 3 of UCH-L1 gene in PD patients (62.2%) was significantly higher than that of the healthy controls(51.7 % )( OR = 1.53, P = 0. 006), as was the C/C genotype (OR = 1.90, P = 0.008). (2)There was no significant difference in the distribution of the C/T allele and genotypes in exon 4 between PD patients and healthy controls. Conclusion The C allele in exon 3 of UCH-L1 gene might be one of the risk factors for PD in Shanghai Hart Nationality, but the polymorphisms of C/T in exon 4 showed no association with the onset of PD.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2008年第3期272-275,共4页 Chinese Journal of Medical Genetics
关键词 帕金森病 泛素羧基端水解酶-L1 基因 遗传多态性 Parkinson's disease ubiquitin carbexy-terminal hydrolase-L1 gene genetic polymorphism
  • 相关文献

参考文献11

  • 1Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson' s disease. Nature, 1998,395:451-452.
  • 2The extrapyramidal disease conference in China. Diagnostic criteria and differential diagnosis of Parkinson' disease and Parkinson' s syndrome. Chin J Neuro, 1985,18:256.
  • 3Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson' s disease. Science, 2003,302: 819-822.
  • 4Osaka H, Wang YL,Takada K, et al. Ubiquitin carboxy-tenninal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum Mol Genet ,2003, 12 : 1945-1958.
  • 5Maraganore DM,Farrer MJ,Hardy JA, et al. Case-control study of the ubiquitin carboxy-tenninal hydrolase L1 gene in Parkinson's disease. Neurology, 1999,53 : 1858-1860.
  • 6Wintermeyer P, Kruger R, Kuhn W, et al. Mutation analysis and association studies of the UCHL1 gene in German Parkinson' s disease patients. Neuroreport , 2000,11:2079-2082.
  • 7Momose Y,Murata M, Kobayashi K, et al. Association studies of multiple candidate genes for Parkinson' s disease using single nucleotide polymorphism. Ann Neurol,2002,51 : 133-136.
  • 8Tan EK, Puong KY, Fook-Chong S, et al. Case-control study of UCHL1 S18Y variant in Parkinson's disease. Mov Disord,2006,21 : 1765-1768.
  • 9Healy DG, Abou-Sleiman PM, Wood NW. Genetic causes of Parkinson' s disease: UCHL-1. Cell Tissue Res ,2004,318:189-194.
  • 10Nishikawa K, Li H, Kawamura R, et al. Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-tenninal hydrolase L1 variants. Biochem Biophys Res Commun , 2003,304: 176-183.

同被引文献2

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部